Coldstream Capital Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$844K Sell
11,863
-2,552
-18% -$201K 0.01% 513
2025
Q4
$1.18M Buy
14,415
+1,155
+9% +$90K 0.02% 405
2025
Q3
$996K Sell
13,260
-899
-6% -$67.1K 0.01% 464
2025
Q2
$1.05M Buy
14,159
+3,005
+27% +$209K 0.02% 411
2025
Q1
$900K Buy
11,154
+1,133
+11% +$97.4K 0.02% 401
2024
Q4
$783K Buy
10,021
+457
+5% +$38.8K 0.02% 433
2024
Q3
$891K Buy
9,564
+965
+11% +$81K 0.02% 412
2024
Q2
$670K Buy
8,599
+1,890
+28% +$154K 0.02% 438
2024
Q1
$610K Buy
6,709
+2,247
+50% +$187K 0.02% 483
2023
Q4
$345K Buy
4,462
+942
+27% +$66K 0.01% 653
2023
Q3
$240K Sell
3,520
-411
-10% -$29.9K 0.01% 681
2023
Q2
$319K Buy
3,931
+31
+0.8% +$2.47K 0.01% 603
2023
Q1
$320K Buy
+3,900
New +$278K 0.01% 598

Other funds holding GEHC

Coldstream Capital Management's GEHC Position: Q1 2026 in Review

Coldstream Capital Management reduced its GE HealthCare (GEHC) stake by 18% in Q1 2026, selling an estimated $201K and leaving 11,863 shares worth $844K. The position accounts for 0.01% of the portfolio, ranked #513.

Coldstream Capital Management first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.18M in Q4 2025. 1,269 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Coldstream Capital Management held 11,863 shares of GE HealthCare worth $844K as of Q1 2026.
  • Coldstream Capital Management sold 2,552 GE HealthCare shares in Q1 2026, an estimated $201K.
  • GE HealthCare made up 0.01% of Coldstream Capital Management's portfolio in Q1 2026, its #513 holding.
  • Coldstream Capital Management first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Coldstream Capital Management's GE HealthCare position peaked at $1.18M in Q4 2025.
  • 1,269 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Coldstream Capital Management's 13F filing for Q1 2026, filed 8 May 2026.